Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-2-24
pubmed:abstractText
The present study compared the therapeutic activity of intravesical BCG with intravesical mitomycin C chemotherapy in patients with non-muscle invasive bladder cancer at intermediate risk of recurrence in a prospective randomised trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1124-3562
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
167-71
pubmed:meshHeading
pubmed-meshheading:19235434-Adjuvants, Immunologic, pubmed-meshheading:19235434-Administration, Intravesical, pubmed-meshheading:19235434-Adult, pubmed-meshheading:19235434-Aged, pubmed-meshheading:19235434-Aged, 80 and over, pubmed-meshheading:19235434-Antibiotics, Antineoplastic, pubmed-meshheading:19235434-BCG Vaccine, pubmed-meshheading:19235434-Female, pubmed-meshheading:19235434-Humans, pubmed-meshheading:19235434-Male, pubmed-meshheading:19235434-Middle Aged, pubmed-meshheading:19235434-Mitomycin, pubmed-meshheading:19235434-Neoplasm Invasiveness, pubmed-meshheading:19235434-Neoplasm Recurrence, Local, pubmed-meshheading:19235434-Prospective Studies, pubmed-meshheading:19235434-Risk Factors, pubmed-meshheading:19235434-Time Factors, pubmed-meshheading:19235434-Urinary Bladder Neoplasms
pubmed:year
2008
pubmed:articleTitle
A randomized prospective study of intravesical prophylaxis in non-musle invasive bladder cancer at intermediate risk of recurrence: mitomycin chemotherapy vs BCG immunotherapy.
pubmed:affiliation
Urology Unit, Ospedale S. Paolo, Milano, Italy.
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial